Elon Musk’s star power fails to help far-right AfD win German election

“This is no time for complacency,” the Federal Reserve Bank of Atlanta president wrote. Read More https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-1763956102-e1740068890327.jpg?resize=1200,600 2025-02-20 16:30:46

Walmart also reported lower quarterly revenue than Amazon for the first time ever. Read More https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-1921426381-e1740088267132.jpg?resize=1200,600 2025-02-20 21:55:56

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal InformationFORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive…

China’s tech earnings this week now give an early glimpse into how its tech CEOs are thinking about DeepSeek. Read More https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-2200128165-e1740148276842.jpg?resize=1200,600 2025-02-21 14:43:00

Unilever’s local rivals’ “game is simple: just cut the price,” said Willy Goutama, an equity analyst at PT Maybank Sekuritas Indonesia. Read More https://fortune.com/img-assets/wp-content/uploads/2025/03/GettyImages-2048711238-e1740809840452.jpg?resize=1200,600 2025-03-01 06:20:30

Novo Nordisk’s semaglutide weight-loss (Wegovy) and diabetes (Ozempic) drugs are no longer in short supply, U.S. regulators said Feb. 21, 2025, a decision that’s expected to curtail widespread access to cheaper copies of the popular medications. Steve Christo/Corbis/Getty Images https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-2193602916-e1740168016500.jpg?resize=1200,600 2025-02-21 20:03:47